Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Notice to Readers: New CDC Materials Regarding Fetal Alcohol Spectrum Disorders
April has been designated Alcohol Awareness Month in the United States to call attention to the problem of alcohol abuse and alcohol-related issues. Alcohol awareness is particularly important for women who are pregnant or planning a pregnancy. Prenatal alcohol exposure is one of the leading preventable causes of birth defects and developmental disabilities. Effective strategies are needed to 1) identify women at risk and intervene and 2) diagnose and treat children with fetal alcohol spectrum disorders (FASDs).
CDC has developed new materials that can guide in the identification, prevention, and management of FASDs. These products include a curriculum development guide for use with health-care students and practitioners and recommendations from the National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect on promoting and improving strategies to 1) reduce alcohol use and alcohol-exposed pregnancies and 2) improve early identification, diagnostic services, and research on interventions for children with FASDs and their families. These new materials are available at http://www.cdc.gov/fasd.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services. |
All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Date last reviewed: 4/22/2009